Latest Raloxifene Stories
NCCN announces new updates to the NCCN Guidelines for Breast Cancer and Breast Cancer Risk Reduction Guidelines.
COLLEGEVILLE, Pa., Sept.
By Solimeo, Samantha Osteoporosis is a metabolic bone disorder characterized by low bone density and associated with atraumatic fractures, pain, disability, long-term-care placement, and premature mortality.
The North American Menopause Society (NAMS) has just released a supplement to its official journal Menopause to meet the need for current clinical recommendations for managing breast cancer risk in postmenopausal women.
By Verdier-Sevrain, S ABSTRACT Estrogens have a profound influence on skin. The relative hypoestrogenism that accompanies menopause exacerbates the deleterious effects of both intrinsic and environmental aging. Estrogens prevent skin aging. They increase skin thickness and improve skin moisture.
By Zaborowska, E; Brynhildsen, J; Damberg, S; Fred
By Scharla, S; Oertel, H; Helsberg, K; Kessler, F;
Tamoxifen, the pill that prevents breast cancer in high-risk women, does not appear in the long run to save many lives, U.S. researchers reported on Monday.
NEW YORK (Reuters Health) - Treatment with raloxifene appears to reduce heart rate variability in elderly women with osteoporosis, Turkish researchers report in the American Journal of Obstetrics and Gynecology.
The osteoporosis drug Evista works as well as tamoxifen in reducing the risk of breast cancer in high-risk older women, with fewer dangerous side effects, researchers said on Monday.
- A hairdresser.